JanaNeuber (Talk | contribs) |
|||
(79 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
+ | |||
{{Freiburg/Navbar}} | {{Freiburg/Navbar}} | ||
− | |||
<html> | <html> | ||
<head> | <head> | ||
+ | </head> | ||
<style> | <style> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
/* .body { | /* .body { | ||
Line 204: | Line 171: | ||
.cool_container { | .cool_container { | ||
width: 100%; | width: 100%; | ||
− | padding-top: | + | padding-top: 280px; |
margin-bottom: -100px; | margin-bottom: -100px; | ||
} | } | ||
Line 215: | Line 182: | ||
margin: 0 auto; | margin: 0 auto; | ||
position: relative; | position: relative; | ||
− | width: | + | width: 30%; |
height: 250px; | height: 250px; | ||
top: -530px; | top: -530px; | ||
Line 224: | Line 191: | ||
} | } | ||
− | #Abstract_logo{ | + | #Abstract_logo { |
position: relative; | position: relative; | ||
− | transform: translate(- | + | transform: translate(-20%, 50%); |
− | -ms-transform: translate(- | + | -ms-transform: translate(-20%, 50%); |
− | -o-transform: translate(- | + | -o-transform: translate(-10%, 50%); |
− | -webkit-transform: translate(- | + | -webkit-transform: translate(-10%, 50%); |
} | } | ||
+ | |||
/* =============== END: Circle of Elements - Center Image ==================== */ | /* =============== END: Circle of Elements - Center Image ==================== */ | ||
Line 270: | Line 238: | ||
.element1 { | .element1 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/b/b5/T-FREIBURG-Mafiadude_z_medalami2.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 276: | Line 244: | ||
.element2 { | .element2 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/c/c4/T-FREIBURG-mafiadude-team3.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 282: | Line 250: | ||
.element3 { | .element3 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/4/4d/T-FREIBURG-mafiadude-andgate2.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 288: | Line 256: | ||
.element4 { | .element4 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/8/82/T-FREIBURG-mafiadude-diploma2.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 294: | Line 262: | ||
.element5 { | .element5 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/4/43/T-FREIBURG-mafiadude-modeling.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 300: | Line 268: | ||
.element6 { | .element6 { | ||
− | background-image: url("https://static.igem.org/mediawiki/2017/ | + | background-image: url("https://static.igem.org/mediawiki/2017/3/3d/T-FREIBURG-mafiadude-hp.png"); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 312: | Line 280: | ||
.element8 { | .element8 { | ||
− | background-image: url(" | + | background-image: url(""); |
background-size: cover; | background-size: cover; | ||
background-position: center; | background-position: center; | ||
Line 536: | Line 504: | ||
</script> | </script> | ||
− | < | + | <div class="body"> |
− | + | ||
− | + | ||
− | + | ||
− | |||
<div class="cool_container"> | <div class="cool_container"> | ||
Line 550: | Line 514: | ||
<div class="cool_image_blink element1"> | <div class="cool_image_blink element1"> | ||
− | <div class="cool_content cool_text_blink link_trigger" href= | + | <div class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Achievements" title=""> |
<div class="text"> | <div class="text"> | ||
− | Besides learning a lot and having | + | Besides learning <br> a lot and having fun, we achieved something great this year! |
Check it out! | Check it out! | ||
Line 558: | Line 522: | ||
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href= | + | <div class="cool_header"><a href="https://2017.igem.org/Team:Freiburg/Achievements">Achievements</a></div> |
</div> | </div> | ||
</li> | </li> | ||
Line 565: | Line 529: | ||
<div id="box2" class="topicboxes"> | <div id="box2" class="topicboxes"> | ||
<div class="cool_image_blink element2"> | <div class="cool_image_blink element2"> | ||
− | <div class="cool_content cool_text_blink link_trigger" href="" title=""> | + | <div class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Team" title=""> |
− | + | <br>Find out more <br> about the Freiburg 2017 team and our members! | |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href=''>Team</a></div> | + | <div class="cool_header"><a href='https://2017.igem.org/Team:Freiburg/Team'>Team</a></div> |
</div> | </div> | ||
</li> | </li> | ||
Line 577: | Line 541: | ||
<div class="cool_image_blink element3"> | <div class="cool_image_blink element3"> | ||
− | <div class="cool_content cool_text_blink link_trigger" href= | + | <div class="cool_content cool_text_blink link_trigger" href="https://2017.igem.org/Team:Freiburg/Design" title="AND gate"> |
− | + | To make our approach safer, we are integrating two inputs into one output. Have a look! | |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href= | + | <div class="cool_header"><a href="https://2017.igem.org/Team:Freiburg/Design">AND Gate</a></div> |
</div> | </div> | ||
</li> | </li> | ||
Line 590: | Line 554: | ||
<div class="cool_image_blink element4"> | <div class="cool_image_blink element4"> | ||
− | <div class="cool_content cool_text_blink link_trigger" href='' title=""> | + | <div class="cool_content cool_text_blink link_trigger" href='https://2017.igem.org/Team:Freiburg/Results' title=""> |
− | We generated stable cell lines, a | + | We generated <br> stable cell lines, a gene knockdown, characterized several promoters and much more! |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href= | + | <div class="cool_header"><a href="https://2017.igem.org/Team:Freiburg/Results">Results</a></div> |
</div> | </div> | ||
</li> | </li> | ||
Line 602: | Line 566: | ||
<div class="cool_image_blink element5"> | <div class="cool_image_blink element5"> | ||
− | <div class="cool_content cool_text_blink link_trigger" href='' title=""> | + | <div class="cool_content cool_text_blink link_trigger" href='https://2017.igem.org/Team:Freiburg/Model' title=""> |
− | To better understand our | + | To better <br> understand our AND gate, we modeled gene expression within our genetic circuit. |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href=''>Modeling</a></div> | + | <div class="cool_header"><a href='https://2017.igem.org/Team:Freiburg/Model'>Modeling</a></div> |
</div> | </div> | ||
</li> | </li> | ||
Line 614: | Line 578: | ||
<div class="cool_image_blink element6"> | <div class="cool_image_blink element6"> | ||
− | <div class="cool_content cool_text_blink link_trigger | + | <div class="cool_content cool_text_blink link_trigger" href='https://2017.igem.org/Team:Freiburg/HP/Silver' title=""> |
− | + | To hear thoughts about our project, check out our survey and interviews with experts working on the topic! | |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="cool_header"><a href=''>Human Practice</a></div> | + | <div class="cool_header"><a href='https://2017.igem.org/Team:Freiburg/HP/Silver'>Human Practice</a></div> |
</div> | </div> | ||
</li> | </li> | ||
+ | |||
Line 626: | Line 591: | ||
<div class="cool_centerimage"> | <div class="cool_centerimage"> | ||
<div id="Abstract_logo"> | <div id="Abstract_logo"> | ||
− | + | <a href="https://2017.igem.org/Team:Freiburg/Introduction" title="Start guided tour"> <img src="https://static.igem.org/mediawiki/2017/7/74/T-FREIBURG-cartel.png" height="150px" width="340px"></a> | |
</div> | </div> | ||
</div> | </div> | ||
− | + | ||
+ | |||
+ | </div> | ||
</div> | </div> | ||
+ | |||
+ | |||
<div class="container"> | <div class="container"> | ||
<div class="row"> | <div class="row"> | ||
<div class="col-md-12 text-center"> | <div class="col-md-12 text-center"> | ||
− | <div class="flex-container | + | <div class="flex-container" style="margin-top:-20%;padding-right:10%;"> |
− | + | <div class="item"> | |
− | + | <h2 style="font-size:40px; padding-top: 50px" align="center">Abstract</h2> | |
− | + | <p>A new approach to cancer treatment is the chimeric antigen receptor (CAR) T cell therapy, which shows promising results fighting tumors in clinical trials. It consists of autologous isolated T cells modified with a chimeric receptor based on the T-cell receptor combined with the recognition domain of an antibody. Upon reinjection, CAR T cells exhibit cytotoxicity with high affinity towards cells displaying the antigen. However, clinical trials have shown that as tumor antigens are not solely expressed on tumor cells, but also on healthy tissues, grave off-target effects like the Graft-versus-Host-Disease may occur. In order to avoid such side-effects, we engineer CAR T cell lines specifically activated by factors of the tumor microenvironment. Controlled by a genetic AND gate system the T cells need two input signals in order to express CAR. This would allow highly localized cytotoxic activity of T cells and provide safer cell-based cancer immunotherapy especially for solid tumors.</p> | |
− | + | </div> | |
− | <div class=" | + | |
− | + | ||
− | <p>A new approach to cancer treatment is the chimeric antigen receptor (CAR) therapy, which shows promising results fighting tumors in clinical trials. It consists of autologous isolated T cells modified with a chimeric receptor based on the T-cell receptor combined with the recognition domain of an antibody. Upon reinjection, CAR T cells exhibit cytotoxicity with high affinity towards cells displaying the antigen. However, clinical trials have shown that as tumor antigens are not solely expressed on tumor cells, but also on healthy tissues, grave off-target effects like the Graft-versus-Host-Disease may occur. In order to avoid such side-effects, we engineer CAR T cell lines specifically activated by factors of the tumor microenvironment. Controlled by a genetic AND gate system the T cells need two input signals in order to express CAR. This would allow highly localized cytotoxic activity of T cells and provide safer cell-based cancer immunotherapy especially for solid tumors.</p> | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | </div> | + | |
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
− | |||
</html> | </html> | ||
− | |||
{{Freiburg/Footer}} | {{Freiburg/Footer}} |
Latest revision as of 01:52, 2 November 2017
-
Besides learning
a lot and having fun, we achieved something great this year! Check it out! -
Find out more
about the Freiburg 2017 team and our members! -
To make our approach safer, we are integrating two inputs into one output. Have a look!
-
We generated
stable cell lines, a gene knockdown, characterized several promoters and much more! -
To better
understand our AND gate, we modeled gene expression within our genetic circuit. -
To hear thoughts about our project, check out our survey and interviews with experts working on the topic!
Abstract
A new approach to cancer treatment is the chimeric antigen receptor (CAR) T cell therapy, which shows promising results fighting tumors in clinical trials. It consists of autologous isolated T cells modified with a chimeric receptor based on the T-cell receptor combined with the recognition domain of an antibody. Upon reinjection, CAR T cells exhibit cytotoxicity with high affinity towards cells displaying the antigen. However, clinical trials have shown that as tumor antigens are not solely expressed on tumor cells, but also on healthy tissues, grave off-target effects like the Graft-versus-Host-Disease may occur. In order to avoid such side-effects, we engineer CAR T cell lines specifically activated by factors of the tumor microenvironment. Controlled by a genetic AND gate system the T cells need two input signals in order to express CAR. This would allow highly localized cytotoxic activity of T cells and provide safer cell-based cancer immunotherapy especially for solid tumors.